Search - tctmd.com

Displaying 561 - 580 of 1806

Sort: Relevancy | Date

News Industry News

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

July 24, 2019

News Daily News

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Marcus A. Banks

July 22, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Smart Device Shows Promise in Identifying Out-of-Hospital Cardiac Arrest

Yael L. Maxwell

July 02, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Industry News

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

June 19, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Presenter: Samir Kapadia

June 13, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Industry News

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

June 04, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Industry News

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

May 14, 2019

Advertisement

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Smart Device Shows Promise in Identifying Out-of-Hospital Cardiac Arrest

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Highlights From the PARTNER 3 Low-Risk Trial

The PARTNER 3 Low-Risk Randomized Trial

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

TAVR Operators: Can One Do It All or Are Two Still Justified?

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content